An epoxyisoprostane is a major regulator of endothelial cell function

Journal of Medicinal Chemistry

Volumn 56, Issue 21, 2013, Pages 8521-8532

  Zhong, Wei ^a   Springstead, James R ^a   Al Mubarak, Ramea ^b   Lee, Sangderk ^a   Li, Rongsong ^c   Emert, Benjamin ^a   Berliner, Judith A ^a   Jung, Michael E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Parkview Campus   (United States)

^c University of Southern California ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 PALMITOYL 2 (5,6 EPOXYISOPROSTANE E2) SN GLYCERO 3 PHOSPHOCHOLINE; 5,6 EPOXYISOPROSTANE; ANTIINFLAMMATORY AGENT; CHOLINE DERIVATIVE; CXCL1 CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GRANULOCYTE CHEMOTACTIC PROTEIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; ISOPROSTANE DERIVATIVE; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEAR FACTOR KAPPA B 1 A; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL FUNCTION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG SYNTHESIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; STEREOISOMERISM; TRANS ISOMER;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-1BETA; ISOPROSTANES; MOLECULAR CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84887893359     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm400959q     Document Type: Article

References (31)

1. Lee, S.; Birukov, K. G.; Romanoski, C. E.; Springstead, J. R.; Lusis, A. J.; Berliner, J. A. Role of phospholipid oxidation products in atherosclerosis Circ. Res. 2012, 111, 778-799
2. Leitinger, N. Oxidized phospholipids as modulators of inflammation in atherosclerosis Curr. Opin. Lipidol. 2003, 14, 421-430
3. Springstead, J. R.; Gugiu, B. G.; Lee, S.; Cha, S.; Watson, A. D.; Berliner, J. A. Evidence for the importance of OxPAPC interaction with cysteines in regulating endothelial cell function J. Lipid Res. 2012, 53, 1304-1315
4. Subbanagounder, G.; Leitinger, N.; Schwenke, D. C.; Wong, J. W.; Lee, H.; Rizza, C.; Watson, A. D.; Faull, K. F.; Fogelman, A. M.; Berliner, J. A. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn -2 position Arterioscler., Thromb., Vasc. Biol. 2000, 20, 2248-2254
5. Podrez, E. A.; Byzova, T. V.; Febbraio, M.; Salomon, R. G.; Ma, Y.; Valiyaveettil, M.; Poliakov, E.; Sun, M.; Finton, P. J.; Curtis, B. R.; Chen, J.; Zhang, R.; Silverstein, R. L.; Hazen, S. L. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype Nat. Med. 2007, 13, 1086-1095
6. Oskolkova, O. V.; Afonyushkin, T.; Preinerstorfer, B.; Bicker, W.; von Schlieffen, E.; Hainzl, E.; Demyanets, S.; Schabbauer, G.; Lindner, W.; Tselepis, A. D.; Wojta, J.; Binder, B. R.; Bochkov, V. N. Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation J. Immunol. 2010, 185, 7706-7712
7. Romanoski, C. E.; Che, N.; Yin, F.; Mai, N.; Pouldar, D.; Civelek, M.; Pan, C.; Lee, S.; Vakili, L.; Yang, W. P.; Kayne, P.; Mungrue, I. N.; Araujo, J. A.; Berliner, J. A.; Lusis, A. J. Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1 Circ. Res. 2011, 109, e27-41
8. Berliner, J. A.; Watson, A. D. A role for oxidized phospholipids in atherosclerosis N. Engl. J. Med. 2005, 353, 9-11
9. Subbanagounder, G.; Wong, J. W.; Lee, H.; Faull, K. F.; Miller, E.; Witztum, J. L.; Berliner, J. A. Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta J. Biol. Chem. 2002, 277, 7271-7281
10. Cole, A. L.; Subbanagounder, G.; Mukhopadhyay, S.; Berliner, J. A.; Vora, D. K. Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway Arterioscler., Thromb., Vasc. Biol. 2003, 23, 1384-1390
11. Watson, A. D.; Subbanagounder, G.; Welsbie, D. S.; Faull, K. F.; Navab, M.; Jung, M. E.; Fogelman, A. M.; Berliner, J. A. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein J. Biol. Chem. 1999, 274, 24787-24798
12. Jung, M. E.; Berliner, J. A.; Angst, D.; Yue, D.; Koroniak, L.; Watson, A. D.; Li, R. Total synthesis of the epoxy isoprostane phospholipids PEIPC and PECPC Org. Lett. 2005, 7, 3933-3935
13. Jung, M. E.; Berliner, J. A.; Koroniak, L.; Gugiu, B. G.; Watson, A. D. Improved synthesis of the epoxy isoprostane phospholipid PEIPC and its reactivity with amines Org. Lett. 2008, 10, 4207-4209
14. Basra, S. K.; Drew, M. G. B.; Mann, J.; Kane, P. D. A novel approach to bis-isoxazolines using a latent form of cyclopentadienone J. Chem. Soc., Perkin Trans. 1 2000, 3592-3598
15. Rai, A. N.; Basu, A. An efficient method for para-methoxybenzyl ether formation with lanthanum triflate Tetrahedron Lett. 2003, 44, 2267-2269
16. Gemal, A. L.; Luche, J.-L. Lanthanoids in organic synthesis. 6. Reduction ofα-enones by sodium borohydride in the presence of lanthanoid chlorides: synthetic and mechanistic aspects J. Am. Chem. Soc. 1981, 103, 5454-5459
17. Curran, T. T.; Hay, D. A.; Koegel, C. P.; Evans, J. C. The preparation of optically active 2-cyclopenten-1,4-diol derivatives from furfuryl alcohol Tetrahedron 1997, 53, 1983-2004
18. Mukaiyama, T. Titanium tetrachloride in organic-synthesis Angew. Chem., Int. Ed. Engl. 1977, 16, 817-826
19. Lipshutz, B. H.; Ellsworth, E. L.; Dimock, S. H.; Smith, R. A. J. Understanding allylic organocuprates-sigma-bound or pi-bound reagents J. Org. Chem. 1989, 54, 4977-4979
20. Lipshutz, B. H.; Crow, R.; Dimock, S. H.; Ellsworth, E. L.; Smith, R. A. J.; Behling, J. R. Ligand-exchange between cyanocuprates and allylic stannanes-a novel, direct route to allylic cuprates possessing remarkable reactivity and stability J. Am. Chem. Soc. 1990, 112, 4063-4064
21. Kirii, H.; Niwa, T.; Yamada, Y.; Wada, H.; Saito, K.; Iwakura, Y.; Asano, M.; Moriwaki, H.; Seishima, M. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice Arterioscler., Thromb., Vasc. Biol. 2003, 23, 656-660
22. Galea, J.; Armstrong, J.; Gadsdon, P.; Holden, H.; Francis, S. E.; Holt, C. M. Interleukin-1 beta in coronary arteries of patients with ischemic heart disease Arterioscler., Thromb., Vasc. Biol. 1996, 16, 1000-1006
23. Hasdai, D.; Scheinowitz, M.; Leibovitz, E.; Sclarovsky, S.; Eldar, M.; Barak, V. Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease Heart 1996, 76, 24-28
24. Dewberry, R.; Holden, H.; Crossman, D.; Francis, S. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis Arterioscler., Thromb., Vasc. Biol. 2000, 20, 2394-2400
25. Starosta, V.; Wu, T.; Zimman, A.; Pham, D.; Tian, X.; Oskolkova, O.; Bochkov, V.; Berliner, J. A.; Birukova, A. A.; Birukov, K. G. Differential regulation of endothelial cell permeability by high and low doses of oxidized 1-palmitoyl-2-arachidonyl- sn -glycero-3-phosphocholine Am. J. Respir. Cell Mol. Biol. 2012, 46, 331-341
26. Cruz, D.; Watson, A. D.; Miller, C. S.; Montoya, D.; Ochoa, M. T.; Sieling, P. A.; Gutierrez, M. A.; Navab, M.; Reddy, S. T.; Witztum, J. L.; Fogelman, A. M.; Rea, T. H.; Eisenberg, D.; Berliner, J.; Modlin, R. L. Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy J. Clin. Invest. 2008, 118, 2917-2928
27. Egger, J.; Bretscher, P.; Freigang, S.; Kopf, M.; Carreira, E. M. Synthesis of epoxyisoprostanes: effects in reducing secretion of pro-inflammatory cytokines IL-6 and IL-12 Angew. Chem., Int. Ed. 2013, 52, 5382-5385
28. Hakkinen, T.; Luoma, J. S.; Hiltunen, M. O.; Macphee, C. H.; Milliner, K. J.; Patel, L.; Rice, S. Q.; Tew, D. G.; Karkola, K.; Yla-Herttuala, S. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions Arterioscler., Thromb., Vasc. Biol. 1999, 19, 2909-2917
29. Oorni, K.; Kovanen, P. T. Lipoprotein modification by secretory phospholipase A(2) enzymes contributes to the initiation and progression of atherosclerosis Curr. Opin. Lipidol. 2009, 20, 421-427
30. Stafforini, D. M.; Sheller, J. R.; Blackwell, T. S.; Sapirstein, A.; Yull, F. E.; McIntyre, T. M.; Bonventre, J. V.; Prescott, S. M.; Roberts, L. J., 2nd. Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases J. Biol. Chem. 2006, 281, 4616-4623
31. Montuschi, P.; Barnes, P. J.; Roberts, L. J., 2nd. Isoprostanes: markers and mediators of oxidative stress FASEB J. 2004, 18, 1791-1800